Roche Deal History & Licensing Activity

About Roche Licensing & Deal Activity

Roche is a large pharma company based in Switzerland that has been actively engaged in licensing transactions across the biopharma landscape. With 65 deals over the past three years, Roche ranks among the most acquisitive companies tracked by Ambrosia Ventures.

Key therapeutic areas of focus for Roche include Oncology (26 deals and trials), Gastroenterology (24 deals and trials), Solid Tumors (16 deals and trials), and Metabolic (12 deals and trials). In terms of modality, Roche has shown particular interest in antibodies, small molecules, peptides.

Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Roche and 850+ other biopharma companies. Use our deal calculator to benchmark your asset against Roche's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.